Ménétrier's disease. Another Helicobacter pylori associated disease?;Morbus Ménétrier: Endnu en Helicobacter pylori-associeret sygdom?

Ugeskrift for Laeger

Volumn 162, Issue 32, 2000, Pages 4250-4253

  Madsen, Lone Galmstrup ^a   Taskiran, Mustafa ^b   Bytzer, Peter ^b  

^a Amtssygehuset i Glostrup   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTIULCER AGENT; MACROLIDE; OMEPRAZOLE;

ADULT; AGED; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; REVIEW; STOMACH DISEASE; STOMACH MUCOSA;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MACROLIDES; MALE; MIDDLE AGED; OMEPRAZOLE; STOMACH DISEASES;

EID: 0041036230     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Appelman HD. Localized and extensive expansions of the gastric mucosa: mucosal polyps and giant folds. I: Appelman HD. Pathology of the eso-phagus, stomach and duodenum. 4th ed. New York: Churchill Livingstone, 1984; 79-119.
2. Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. Scand J Gastroenterol Suppl 1992; 194: 1-7.
3. Lepore MJ, Smith FB, Bonanno CA. Campylobacter-like organisms in patient with Menetrier's disease (letter). Lancet 1988; I: 466.
4. Salmeron M, Desplaces N, Lavergne A, Houdart R. Campylobacter pylori, hypertrophic erosive gastritis and hypoalbuminemia healed by cephalexin therapy (letter). Gastroenterol Clin Biol 1989; 13: 109-10.
5. Herz R, Lombardi E, Wipping F, Stolte M. Helicobacter pylori-assoziierte Riesenfaltengastritis. Imitation eines Morbus Ménétrier. Fortschr Med 1992; 110: 37-40.
6. Bayerdörffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori - is Helicobacter pylori a pathogenic factor in Menetrier's disease? Gut 1994; 35: 701-4.
7. Groisman GM, George J, Berman D, Harpaz N. Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89: 1548-51.
8. Kawasaki M, Hizawa K, Aoyagi K, Nakamura S, Fujishima M. Menetrier's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. Am J Gastroenterol 1997; 92: 1909-12.
9. Yamada M, Sumazaki R, Adachi H, Ahmed T, Matsubara T, Hori T et al. Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori. Eur J Pediatr 1997; 156: 182-5.
10. Badov D, Lambert JR, Finlay M, Balazs ND. Helicobacter pylori as a pathogenic factor in Menetrier's disease. Am J Gastroenterol 1998; 93: 1976-9.
11. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Yamagata R, Yoshimura T et al. Healing of cimetidine-resistant Menetrier's disease by eradication of Helicobacter pylori infection. J Clin Gastroenterol 1998; 27: 348-50.
12. Kaneko T, Akamatsu T, Gotoh A, Shimodaira K, Shimizu T, Kiyosawa K et al. Remission of Menetrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1999; 94: 272-3.
13. Raderer M, Oberhuber G, Templ E, Wagner L, Potzi R, Wrba F et al. Successful symptomatic management of a patient with Menetrier's disease with long-term antibiotic treatment. Digestion 1999; 60: 358-62.
14. Madsen LG, Taskiran M, Madsen JL, Bytzer P. Menetrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. Dig Dis Sci 1999; 44: 2307-12.
15. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-4.
16. Stolte M, Batz C, Bayerdörffer E, Eidt S. Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995; 33: 198-201.
17. Avunduk C, Navab F, Hampf F, Coughlin B. Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopie ultrasound before and after antimicrobial therapy. Am J Gastroenterol 1995; 90: 1969-73.
18. Stolte M, Batz C, Eidt S. Giant fold gastritis - a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993; 31: 289-93.
19. Occena RO, Taylor SF, Robinson CC, Sokol RJ. Association of cytomegalovirus with Menetrier's disease in childhood: report of two new cases with a review of literature. J Pediatr Gastroenterol Nutr 1993; 17: 217-24.
20. Kindermann A, Koletzko S. Eiweisverlierende Riesenfaltengastritis im Kindersalter - ein Fallberict und Abgrenzung zum Morbus Ménétrier des Erwachsenen-alters. Z Gastroenterol 1998; 36: 165-71.
21. Drut RM, Gomez MA, Lojo MM, Drut R. Cytomegalovirus-associated Menetrier's disease in adults. Demonstration by polymerase chain reac-tion (PCR). Medicina (B Aires) 1995; 55: 659-64.
22. Mendis RE, Gerdes H, Lightdale CJ, Botet JF. Large gastric folds: a diagnostic approach using endoscopie ultrasonography. Gastrointest Endosc 1994; 40: 437-41.
23. Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier's disease: supportive evidence form humans and transgenic mice. Gastroenterology 1992; 103: 1950-63.
24. Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Miyazaki Y et al. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39: 787-94.
25. Sferra TJ, Pawel BR, Qualman SJ, Li BU. Menetrier disease of childhood: role of cytomegalovirus and transforming growth factor alpha. J Pediatr 1996; 128: 213-9.
26. Jarnum S, Jensen KB. Plasma protein turnover (albumin, transferrin, IgG, IgM) in Menetrier's disease (giant hypertrophic gastritis): evidence of non-selective protein loss. Gut 1972; 13: 128-37.
27. Krag E, Frederiksen HJ, Olsen N, Henriksen J. Cimetidine treatment of protein-losing gastropathy (Menetrier's disease). Scand J Gastroenterol 1978; 13: 635-9.
28. Kelly DG, Miller LJ, Malagelada JR, Huizenga KA, Markowitz H. Giant hypertrophic gastropathy (Menetrier's disease): pharmacologic effects on protein leakage and mucosal ultrastructure. Gastroenterology 1982; 83: 581-9.
29. Bradburn DM, Redwood NF, Venables CW, Gunn A. Medical therapy of Menetrier's disease with omeprazole. Digestion 1992; 52: 204-8.
30. Ladas SD, Tassios PS, Malamou HC, Protopapa DP, Raptis SA. Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Menetrier's disease. Eur J Gastroenterol Hepatol 1997; 9: 811-3.
31. Davis GE, O'Rourke MC, Metz JR, Kindig WV, Sweeney JG, Kane KN. Hypertrophic gastropathy symptoms responsive to prednisone. A case report and a review of the literature. J Clin Gastroenterol 1991; 13: 436-41.